CAS 2455427-91-3

AZD0780

CAS: 2455427-91-3

AZD0780

Pureza: ≥95%

Peso molecular: 414.41g/mol

Ref: 54-BUP09434

AZD0780

CAS: 2455427-91-3

AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.Cost-effective and quality-assured.

Fórmula: C₂₀H₂₀F₂N₆O₂

Pureza: 97.61% - 99.74%

Forma y color: Soild

Peso molecular: 414.41

Ref: TM-T64362